Asset Planning Services (Pennsylvania)’s AstraZeneca AZN Stock Holding History

Asset Planning Services (Pennsylvania)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-150	Closed	-$11K	–	263
2018 Q2	$11K	Hold	150	–	–	0.01%	195
2018 Q1	$10K	Hold	150	–	–	0.01%	202
2017 Q4	$10K	Hold	150	–	–	0.01%	209
2017 Q3	$10K	Hold	150	–	–	0.01%	231
2017 Q2	$10K	Hold	150	–	–	0.01%	221
2017 Q1	$9K	Sell	150 -2,400	-94%	-$140K	0.01%	225
2016 Q4	$139K	Buy	2,550 +2,200	+629%	+$125K	0.11%	76
2016 Q3	$23K	Sell	350 -200	-36%	-$13.1K	0.02%	155
2016 Q2	$33K	Buy	550 +400	+267%	+$23.2K	0.03%	156
2016 Q1	$8K	Hold	150	–	–	0.01%	202
2015 Q4	$10K	Hold	150	–	–	0.01%	161
2015 Q3	$10K	Hold	150	–	–	0.01%	157
2015 Q2	$10K	Buy	+150	New	+$10.3K	0.01%	178

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Asset Planning Services (Pennsylvania)'s AZN Position: Q3 2018 in Review

Asset Planning Services (Pennsylvania) sold out of AstraZeneca (AZN) in Q3 2018, closing a stake of 150 shares — an estimated $11K sold.

Asset Planning Services (Pennsylvania) first reported a position in AZN in Q2 2015 and held it in 13 quarters. The position peaked at $139K in Q4 2016. 544 funds tracked by Wall St. Rank hold AZN as of Q3 2018.

Asset Planning Services (Pennsylvania) reported no remaining AstraZeneca position as of Q3 2018 after selling out during the quarter.
Asset Planning Services (Pennsylvania) sold 150 AstraZeneca shares in Q3 2018, an estimated $11K.
Asset Planning Services (Pennsylvania) first reported a position in AstraZeneca in Q2 2015 and held it in 13 quarters.
Asset Planning Services (Pennsylvania)'s AstraZeneca position peaked at $139K in Q4 2016.
544 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2018.

Based on Asset Planning Services (Pennsylvania)'s 13F filing for Q3 2018, filed 9 Nov 2018.